Trademark Overview
On Tuesday, September 17, 2024, a trademark application was filed for GENOUS with the United States Patent and Trademark Office. The USPTO has given the GENOUS trademark a serial number of 98755109. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 17, 2024. This trademark is owned by GENOMATE HEALTH INC.. The GENOUS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Genetic testing for medical purposes, Genetic testing for cancer risk for medical purposes; Genetic testing for medical purposes for detecting genetic predispositions; Genetic counseling; Medical counseling for the medical treatment of genetic predispositions; Providing information about genetic counseling; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized therapy services, clinical decision support services and evidence-based treatment decisions; Consulting services in the field of health care to assist with biomedical and clinical decisions; medical diagnostic testing, monitoring and reporting services in personalized medicine
Biological research and analysis; Medical research services; Scientific research, namely scientific research relating to genetic alterations; Research in the field of genetic diseases; Consulting services in the field of genetic science; Genetic sequencing services for scientific and medical purposes; Providing medical research information in the field of genetics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing for disease, treatment, trial, outcome and molecular diagnostic test results for decision support
